DR. DHARMEN J PATEL MD NPI 1669577797

NPI Information

  • NPI: 1669577797
  • Provider Name: DR. DHARMEN J PATEL, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1410 TUSCULUM BLVD
    SUITE # 2200
    GREENEVILLE, TN
    ZIP 37745
  • Phone: (423) 639-0243

Map and Directions

Get Directions

NPI Details

DR. Dharmen J Patel, MD is a hematology and oncology internal medicine in Greeneville, TN with 36 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Dharmen J Patel, MD NPI is 1669577797. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1410 TUSCULUM BLVD
SUITE # 2200
GREENEVILLE, TN
ZIP 37745-286
Phone: (423) 639-0243
Fax: (423) 639-0628

The NPI 1669577797 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Magnesium level (HCPCS:83735)
  • Red blood count, automated test (HCPCS:85045)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Uric acid level, blood (HCPCS:84550)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Folic acid level, serum (HCPCS:82746)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Urinalysis, manual test (HCPCS:81002)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Bilirubin level, direct (HCPCS:82248)
  • Urine volume measurement (HCPCS:81050)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Administration of pneumococcal vaccine (HCPCS:G0009)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)

The enumeration date for this NPI number is 9/13/2006 and was last updated on 4/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology36738TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
14156452OTHERTENNESSEEBCBST
2P00614346OTHERMEDICARE RR
338779591MEDICAIDTENNESSEE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.